Related Experiment Video
Updated: May 27, 2026

13:49
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
Published on: December 6, 2017
Bacteria-based in vivo peptide library screening using biopanning approach
Ji-Hyeon Choi1, Sang-Hyun Park
1Department of Biological Sciences, Seoul National University, Seoul, 151-742, Republic of Korea.
Journal of Microbiology (Seoul, Korea)
|November 10, 2011
Summary
This study introduces an in vivo peptide library screening system for identifying therapeutic agents. This novel bacterial system efficiently discovers peptides that disrupt protein interactions, overcoming limitations of traditional in vitro methods.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Traditional library screening for therapeutic agents typically occurs in vitro using purified components.
- In vitro identified agents often lack efficacy in cellular environments.
- A need exists for screening systems that identify biologically active molecules within a cellular context.
Purpose of the Study:
- To develop and validate an in vivo peptide library screening system.
- To identify peptides that inhibit protein-protein interactions within living cells.
- To provide a faster and more effective method for discovering therapeutic peptides.
Main Methods:
- Developed an in vivo screening system utilizing bacteriophage lambda's cI repressor reconstitution in bacterial cells.
- Employed a high-density expression peptide library for screening.
- Utilized a multiple-round biopanning approach for peptide enrichment and amplification.
Main Results:
- Successfully established a functional in vivo screening platform within bacterial cells.
- Demonstrated the system's capability to identify peptides that interfere with protein assembly.
- The biopanning approach enhanced the identification of positive peptide hits.
Conclusions:
- The developed in vivo system offers a rapid and efficient method for discovering biologically active peptides.
- This approach overcomes the limitations of in vitro screening for identifying cell-active therapeutic agents.
- The system is suitable for identifying inhibitors of target protein interactions and assembly.

